Perspective
Sep. 3, 2016
Patent program for cancer treatments has its downsides
The U.S. Patent Office's new Patents 4 Patients Program, which offers expedited examination of certain cancer treatment patent applications, is not a panacea: the resulting patent is shorter term. By Courtenay C. Brinckerhoff, Daniel R. Shelton, Jennifer L. Bachori and Lydia B. Choi




The U.S. Patent Office recently launched the "Patents 4 Patients" program to support the "National Cancer Moonshot" initiative - a bold, billion dollar "whole-of-government approach" f...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In